Women and Heart Disease and Cardiac Research in the 21st Century … – Madison County Courier
By Dr. Matthew Watson
Madison County Courier | Women and Heart Disease and Cardiac Research in the 21st Century ... Madison County Courier Tours will include experimental cardiology, molecular genetics, molecular biology, stem cell and organ bioengineering research and will allow for interaction with MMRL scientists and staff. Two special public presentations are planned. At 10:30 AM ... |
‘Sweet Dreams (Are Made of Chemistry)’ – UC Los Angeles
By Dr. Matthew Watson
'Sweet Dreams (Are Made of Chemistry)' UC Los Angeles Absolutely, said Lee, a second-year student majoring in microbiology, immunology and molecular genetics who rewrote the original Eurhythmics lyrics for the video. She calls Garg "a real Chem 14D superhero" who makes organic chemistry "fun and not as ... |
Summer Science, Technology, Engineering and Mathematics Academy Offered … – The Chronicle
By Dr. Matthew Watson
Summer Science, Technology, Engineering and Mathematics Academy Offered ... The Chronicle W.F. West High School and Centralia College are providing a summer academy that will allow area students to explore topics such as science, robotics, engineering, mathematical modeling and molecular genetics. Students entering high school grades will ... |
West Coast wild salmon test negative for three fish diseases – Globe and Mail
By Dr. Matthew Watson
West Coast wild salmon test negative for three fish diseases Globe and Mail Headed by Dr. Brian Riddell, President and CEO of the Pacific Salmon Foundation, and Dr. Kristi Miller, head of molecular genetics for Fisheries and Oceans Canada, the project will screen thousands of salmon for 45 different disease microbes. Dr ... |
Scientists ID Gene Linked to Aggressive Liver Cancer – U.S. News & World Report
By Dr. Matthew Watson
Scientists ID Gene Linked to Aggressive Liver Cancer U.S. News & World Report The gene also can be used to figure out which liver cancer patients might most benefit from experimental drugs that target the cancer's developmental signaling pathways, said Michael Melner, program director of molecular genetics and biochemistry of ... |
Compensation for Human Eggs Approved by Key California Senate Committee, But Not For CIRM Researchers
By Dr. Matthew Watson
California to be paid for their eggs for scientific research
yesterday cleared a key state Senate committee and is likely headed
for the governor's desk.
Bonilla, D-Concord, was approved on a 6-1 vote by the Senate Health
Committee and now goes to the Senate floor. Earlier, it passed the
Assembly on a 54-20 vote.
scientists have chafed under state restrictions that bar compensation
for eggs while that the same time fertility clinics are paying an average of $9,000 a session for eggs, with some prices going as high as $50,000.
affect researchers using grants from the $3 billion California stem
cell agency. The agency's regulations bar compensation for eggs in
the research that it funds. That means that at least a two-tiered
research system would exist in California not to mention another tier
created by federal regulations that differ from both those of the
stem cell agency and those set by the legislation.
Proposition 71, which created the agency in 2004, and cannot be
changed without a 70 percent vote of the legislature. Bonilla's bill
requires only a majority vote.
American Society for Reproductive Medicine, the chief industry
group for the largely unregulated fertility industry.
committee session summarized Bonilla's arguments for the measure in
this fashion:
“This bill seeks to create equity in
the field of medical research compensation by removing the
prohibition on compensation for women participating in oocyte (egg)
donation for medical research. All other research subjects are
compensated for their time, trouble, and inconvenience involved in
participating in research. AB 926 ensures that women are treated
equally to all other research subjects - allowing them to actively
evaluate their participation in research studies. Unfortunately, the
ban on compensation has had serious unintended consequences. It has
led to a de facto prohibition on women’s reproductive research in
California, adversely impacting the same women that the ban intended
to protect. With few oocytes donated, fertility research and
fertility preservation research has been at a standstill. This
greatly affects women suffering from fertility issues and women
facing cancer who would like to preserve their oocytes.”
to the bill including the Center for Genetics and Society in Berkeley
and the Catholic Church. The bill analysis summarized some of the
opposition arguments in this fashion:
“Egg harvesting exposes healthy young
women to multiple synthetic hormones in order to produce many times
the normal number of eggs per cycle. One of the potential harms is
OHSS, which has resulted in hospitalizations and at least a few
documented deaths. These groups state that many experts remain
concerned about the long-term risks of these drugs, especially
their potential impact on infertility and various cancers.
Follow-up research on egg providers, which could establish the
frequency and severity of these adverse outcomes, is widely
recognized to be grossly inadequate.”
objections, opponents also argue that poor and minority women are
likely to be exploited by enterprises seeking their eggs to resell at
a profit.
organizations, including the California stem cell agency, have taken
a position on the bill. The legislation has received little public
attention, although The Sacramento Bee carried an article last March.
Ruha Benjamin, author of "People's Science" and assistant professor at Boston
University, also wrote about the measure in April on the Huffington
Post. Benjamin said,
Thompson compares egg
donation to 'other kinds of physically demanding service work,'
arguing for a 'salary negotiation between the state agency (or
relevant employer) and the donor.' This, she contends, is a 'sensible
and dignified recognition of [the donor's] work, time, and effort.'
And instead of refusing compensation to women, Thompson suggests that
we 'direct our efforts to understanding and minimizing' the risks.
redouble our efforts, because the market in eggs appears to be
expanding from private reproduction to public research, and
increasingly overseas, if the surrogacy
industry is any indication of how 'cheaper' women become a
reserve army of bio-labor in less regulated regions.”
Merksamer Makes Only Bid For Stem Cell Agency Lobbying Contract
By Dr. Matthew Watson
is interested in working for the California stem cell agency – at
least interested enough to put in a bid.
function of the small size of the contract – $65,000 – and the
entrenched nature of CIRM's existing lobbyist – Nielsen, Merksamer,
Parrinello, Gross & Leoni LLP – one of the state Capitol's
larger lobbying firms with $5 million in billings last year.
connection to the $3 billion agency in its 21-page proposal in
response to a CIRM RFA this spring. The firm has been with CIRM since
2005.
a couple of other interesting aspects of the continuing arrangement.
CIRM will run out of money for new grants in 2017, and Nielsen
Merkasamer said,
“Furthermore, as a premier
legislative advocacy and (Nielsen's italics) ballot measure
law ?rm, Nielsen Merksamer can actively and effectively assist CIRM
as it contemplates returning to the voters for additional funding.”
conceal information that normally would be public record. The firm
said,
“Another unique advantage offered by
Nielsen Merksamer is that, unlike the vast majority of lobbying ?rms,
since we are a full-service law ?rm, our relationships with our
clients are subject to the attorney-client privilege.”
“(N)o one understands CIRM’s 'total
picture' better than Nielsen Merksamer. Not only has Nielsen
Merksamer been representing CIRM before the Legislature for the past
decade, but Nielsen Merksamer was also one of the principal drafters
of the aforementioned Proposition 71—which brought CIRM to life.
The depth of Nielsen Merksamer’s familiarity with, and
understanding of, CIRM’s mission and structure, the challenges it
faces, and the promise it holds simply cannot be matched by any other
legislative advocate.”
$65,000 offered by CIRM but would charge only $49,200 annually, about the same as
it has been paid for several years. Steve Merksamer and Gene Erbin,
who drafted portions of Proposition 71, would handle most of CIRM's
affairs. John Moffatt and Missy Johnson would also be available.
instances where it successfully killed legislation opposed by CIRM.
You can read about them in their proposal below.
Stemlogix Stem Cell Therapy Heals Angie the Chimp! – Video
By JoanneRUSSELL25
Stemlogix Stem Cell Therapy Heals Angie the Chimp!
A year ago Stemlogix donated its stem cell technology to veterinarians in Florida to treat a rescue chimpanzee at the "Save The Chimps" facility named Angie. Angie was suffering from an ACL...
By: Stemlogix, LLC
See the rest here:
Stemlogix Stem Cell Therapy Heals Angie the Chimp! - Video
The Alliance for the Advancement of Adult Stem Cell Therapy and Research – Video
By JoanneRUSSELL25
The Alliance for the Advancement of Adult Stem Cell Therapy and Research
Billy Orr is a quadriplegic who spent the last quarter century in a wheelchair. You are watching Billy Orr stand and walk for the first time after having adu...
By: TheStemCellAlliance
See the original post here:
The Alliance for the Advancement of Adult Stem Cell Therapy and Research - Video
SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product …
By daniellenierenberg
MOUNTAIN VIEW, Calif., June 10, 2013 /PRNewswire/ -- SanBio Inc., a California-based regenerative medicine company, announced today that the U.S. Food and Drug Administration has approved their Investigational New Drug application (IND) for the use of SB623, a novel allogeneic stem cell therapy product, in patients suffering from traumatic brain injuries (TBI's). This approval allows the company to proceed with a Phase 1/2a clinical trial testing the safety and feasibility of the therapy. The clinical trial is expected to be carried out at several major hospitals in the United States.
"This is the second clinical program for SanBio," said Keita Mori, SanBio's Chief Executive Officer, "we see this as a clear validation of our development program and a significant broadening of the therapeutic application of our lead product SB623 for the treatment of unaddressed chronic neurological deficits."
"We measure the responses of TBI patients to physical therapy every day. Progress is often painfully slow and incremental," said Dr. Daniel Lu, Principal Investigator, Neuroplasticity and Repair Laboratory and Director, Neuromotor Recovery Research Center, University of California, Los Angeles, "If this new cell therapy approach improves outcomes it could have a dramatic positive effect on many lives."
About Traumatic Brain Injury: According to the Center for Disease Control and Prevention, more the 1.7 million people in the United States sustain a traumatic brain injury each year, resulting in approximately 50,000 deaths and 275,000 hospitalizations. Many of these more severely injured patients suffer permanent disabilities, including loss of motor function and cognitive impairment. Other than physical rehabilitation there is no effective therapy. Direct medical costs and indirect costs such as lost productivity of TBI totaled an estimated $76.5 billion in the United States in 2000.
About SB623: SB623 is a proprietary cell therapy product consisting of cells derived from genetically modified bone marrow stromal cells obtained from healthy adult donors. SB623 is administered adjacent to the damaged area of the brain. SB623 functions by producing factors that aid the regenerative process.
About SanBio: SanBio is a privately held San Francisco Bay Area biotechnology company focused on the discovery and development of new regenerative cell therapy products.
For more information: http://www.san-bio.com
See the rest here:
SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product ...
Genetic Engineering Alters Mosquitoes’ Sense of Smell – Howard Hughes Medical Institute
By Dr. Matthew Watson
Howard Hughes Medical Institute | Genetic Engineering Alters Mosquitoes' Sense of Smell Howard Hughes Medical Institute In one of the first successful attempts at genetically engineering mosquitoes, HHMI researchers have altered the way the insects respond to odors, including the smell of humans and the insect repellant DEET. The research not only demonstrates that ... Genetically-engineered mosquitoes lose nose for humansGizmag Genetic Bug Spray? Scientists Alter Mosquitoes' Sense of SmellGenetic Engineering News Mutant Mosquitoes Lose Ability to Sniff Out HumansLiveScience.com |
Biotechnology: Virtual reality – Nature.com
By Dr. Matthew Watson
Biotechnology: Virtual reality Nature.com Such is life at a 'virtual' biotechnology company, a lean, nimble model that is gaining popularity among cash-hungry start-ups. These companies consist of as few as one full-time employee who oversees a drug from preclinical development to tests in ... |
Webinar on Biotechnology Patents at the US Supreme Court – Patent Docs
By Dr. Matthew Watson
Webinar on Biotechnology Patents at the US Supreme Court Patent Docs Dr. Noonan will discuss these cases and their effects on the biotechnology industry, particularly in view of recent trends at the Supreme Court regarding the scope of patenting, as well as discuss the Supreme Court's decision in Mayo Collaborative ... |
Biotechnology to fight air pollution – euronews
By Dr. Matthew Watson
euronews | Biotechnology to fight air pollution euronews Using biotechnology to fight pollution is the challenge for a European Union research project. Under the spotlight – a specific kind of moss. At the University of Freiburg in Germany, a team of biologists is growing moss, in a controlled environment ... |
What happened when I had my genome sequenced – The Guardian
By Dr. Matthew Watson
The Guardian | What happened when I had my genome sequenced The Guardian Howard Jacob, director of the Human and Molecular Genetics Center in Wisconsin shows Carole Cadwalladr how to use the MyGenome app on her iPad. Photograph: Brent Altomare. At the time, I fumed about that. The information is out there and very shortly ... |
Gene discovery to avoid baby disease – ScienceAlert
By Dr. Matthew Watson
ScienceAlert | Gene discovery to avoid baby disease ScienceAlert WAIMR's Laboratory for Molecular Genetics, headed by UWA Winthrop Professor Nigel Laing and globally recognised for its research into an inherited condition known as nemaline myopathy, coordinated a worldwide research effort that led to the discovery ... |
The A Team: More than a dozen Bainbridge Spartans rise to the top of their class – Bainbridge Island Review
By Dr. Matthew Watson
The A Team: More than a dozen Bainbridge Spartans rise to the top of their class Bainbridge Island Review She intends to double major in molecular genetics and political science and minor in latin. She's even planning for more education after that. “I'm hopefully going to medical school, because I want to be a surgeon,” Papajani said. Her drive is an ... |
Canadian research suggests drug options to mitigate symptoms of deadly Tay … – Regina Leader-Post
By Dr. Matthew Watson
Regina Leader-Post | Canadian research suggests drug options to mitigate symptoms of deadly Tay ... Regina Leader-Post The work was published in the journal Human Molecular Genetics. Tay-Sachs is a genetic condition that develops in children born to parents who are both carriers of the disease. It is found all over the world, but rates are particularly high among ... Readily-available drugs may reduce devastating symptoms of Tay-Sachs diseaseMedical Xpress |
Circadian Rhythms Play Role In Fighting Off Intestinal Bacterial Infections: Study – Huffington Post
By Dr. Matthew Watson
Circadian Rhythms Play Role In Fighting Off Intestinal Bacterial Infections: Study Huffington Post "Salmonella is a good pathogen to study what happens during infection," Manuela Raffatellu, an assistant professor of microbiology and molecular genetics at the university, said in a statement. "We think these findings may be broadly applicable to ... |
Discovering 1 reason why swarming evolved offers tantalizing clues on how … – EurekAlert (press release)
By Dr. Matthew Watson
Discovering 1 reason why swarming evolved offers tantalizing clues on how ... EurekAlert (press release) "There are both costs and benefits to swarming and all other behaviors," said Christoph Adami, MSU professor of microbiology and molecular genetics. "The benefits are discussed all the time. But the litmus test is whether a behavior evolves because of ... |